S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ROIV Roivant Sciences Ltd

10.69

-0.11 (-1.02%)

Jun 21 2024 - Closed

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Roivant Sciences (NASDAQ:ROIV)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Roivant Sciences Charts.

Roivant Sciences (NASDAQ:ROIV)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Roivant Sciences Charts.

Roivant Sciences Ltd News

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 30 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 30 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 30 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 30 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provides Business Update
Thursday 30 May 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 22 May 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 22 May 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 22 May 2024 (1 month ago) • Edgar (US Regulatory)

Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provide Business Update on Thursday, May 30, 2024
Thursday 16 May 2024 (1 month ago) • GlobeNewswire Inc.

Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Million
Tuesday 2 April 2024 (3 months ago) • GlobeNewswire Inc.

Roivant Sciences Set to Join S&P MidCap 400; Sunrun to Join S&P SmallCap 600
Tuesday 26 March 2024 (3 months ago) • PR Newswire (US)

Roivant Reports Financial Results for the Third Quarter Ended December 31, 2023, and Provides Business Update
Tuesday 13 February 2024 (4 months ago) • GlobeNewswire Inc.

More Roivant Sciences Ltd News Articles

Beiersdorf (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions